Rai G S, Wilkinson R, Elliott R W, Uldall P R, Taylor R M
Clin Nephrol. 1976 Sep;6(3):375-8.
The effect of recurrent early homograft rejection on subsequent patient and renal graft survival. Two hundred renal transplants performed in Newcastle between 1968 and 1974 and followed up for at least 6 months are reviewed. There was a significant fall ingraft survival at 1 year in those patients who suffered a rejection episode during the first two months post-transplant and this fall became greater with each successive rejection episode. The rise in patient mortality with increasing numbers of rejections showed a similar trend but was less (40-50% at 1 year in those suffering 3 or 4 rejection episodes) and did not reach statistical significance beyond the first episode. We, therefore, conclude that in patients not suitable for home dialysis and in whom, because of uncommon tissue type, a second transplant is not likely to be offered under prevailing conditions of kidney donor shortage, it is justifiable to treat third and fourth rejections occurring during the first two months.
早期同种异体移植反复排斥对后续患者及肾移植存活的影响。对1968年至1974年在纽卡斯尔进行的200例肾移植进行回顾,这些移植至少随访了6个月。在移植后前两个月发生排斥反应的患者中,1年时移植肾存活率显著下降,且每次连续发生排斥反应时这种下降幅度更大。随着排斥反应次数增加,患者死亡率上升呈现类似趋势,但幅度较小(发生3次或4次排斥反应的患者1年时死亡率为40 - 50%),且在首次排斥反应之后未达到统计学显著性。因此,我们得出结论,对于不适合家庭透析且由于组织类型罕见在当前肾供体短缺情况下不太可能获得第二次移植的患者,治疗移植后前两个月发生的第三次和第四次排斥反应是合理的。